XML 51 R33.htm IDEA: XBRL DOCUMENT v3.25.2
SEGMENT REPORTING (Tables)
12 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Schedule of segment operating loss and asset information
          
   Operating loss  Assets
United States (RENB)  $15,530,056   $1,907,647 
United States (BioSymetrics)   237,880    6,109,643 
Netherlands (RENC)   173,198,066    213,550 
   $188,966,002   $8,230,840 
Schedule of information regarding segment reporting
                    
   RENB  BioSymetrics  RENC  Total
General and administrative  $14,904,855   $211,401   $2,763,794   $17,880,050 
Research and development   502,896    26,029    8,503    537,428 
Goodwill impairment           170,419,429    170,419,429 
Depreciation and amortization   122,305    450    6,340    129,095 
                     
Segment operating loss  $15,530,056   $237,880   $173,198,066    188,966,002 

 

Geographic information:

 

RENB, BioSymetrics and RENC are managed on a worldwide basis but operate in offices located in the United States and the Netherlands, respectively. The geographic information analyses the Company’s operations and assets based on the country in which each segment operates. In presenting this geographic information, segment operating results have been based on the geographic location in which the services were provided to the segment and segment assets were based on the geographic location of the assets.